Key result
Preoperative radiotherapy plus surgery cuts retroperitoneal sarcoma recurrence ~42% versus surgery alone but increases complications.
Why the study?
The efficacy of preoperative radiotherapy combined with surgery for primary retroperitoneal sarcoma remains unclear.
Does preoperative radiotherapy combined with surgery reduce local recurrence in patients with primary retroperitoneal sarcoma compared to surgery alone?
Meta-Analysis (n=3,892)
Does preoperative radiotherapy combined with surgery reduce local recurrence in patients with primary retroperitoneal sarcoma compared to surgery alone?
Hazard Ratio: 0.575 (95% CI 0.382–0.864)
p-value: p=0.008
Preoperative radiotherapy combined with surgery reduces local recurrence in primary retroperitoneal sarcoma, particularly in well-differentiated and low-grade dedifferentiated liposarcoma, but increases complications without improving overall survival.
Supports preoperative radiotherapy to reduce local recurrence in retroperitoneal sarcoma despite higher complications; strengthens meta-analytic evidence for individualized decisions.
The efficacy of preoperative radiotherapy combined with surgery (preRT + S) for primary retroperitoneal sarcoma (RPS) remains unclear. This study aimed to compare preRT + S with surgery alone (SA) in patients with RPS. Core databases were searched for directly comparative studies depending on preRT. Thirteen studies included 2,439 patients with SA and 1,453 with preRT + S. PreRT + S in all RPS patients led to significantly low local recurrence (LR) (hazard ratios [HR],0.575; p = 0.008) compared to SA. Among the liposarcoma patients, PreRT + S did not clearly affect LR or abdominal recurrence-free survival (ARFS). Excluding dedifferentiated liposarcoma (DDLPS), the patients underwent preRT + S significantly improved LR (HR,0.430; p = 0.002) and ARFS (HR,0.706; p = 0.045). In another subgroup analysis of patients with well-differentiated liposarcoma and grade 1-2 DDLPS, preRT + S significantly extended ARFS (HR,0.601; p = 0.014) compared to SA. There was no significant difference in overall survival (OS) (HR,0.904; p = 0.362 [RPS]; HR,0.724; p = 0.348 [WDLPS + G1-2DDLPS]) between preRT + S and SA in all comparisons. PreRT + S group demonstrated higher incidence of total (odds ratio [OR],1.580; p = 0.007) and severe (OR,3.680; p = 0.004) complications than the SA group. PreRT + S prevent recurrence in patients with WDLPS and low-grade DDLPS but is associated with increased complications, resulting in similar OS compared to SA.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) conducted a meta-analysis in Primary retroperitoneal sarcoma (n=3,892). Preoperative radiotherapy combined with surgery vs. Surgery alone was evaluated on Local recurrence (HR 0.575, 95% CI 0.382-0.864, p=0.008). Preoperative radiotherapy combined with surgery significantly reduced local recurrence (HR 0.575) compared to surgery alone in primary retroperitoneal sarcoma, but increased complications.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: